At CROI 2025, researchers from Université de Montréal discuss how fostemsavir could target residual viral fragments and reduce inflammation.
Mehdi Benlarbi
Advertisement
PhD Student at Univsersité de Montréal.
Articles by Mehdi Benlarbi
Advertisement
Latest Updated Articles
Targeting Soluble gp120 to Combat Immune Dysfunction in People Living with HIVPublished: March 10th 2025 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Antibiotic De-Escalation Demonstrates Advantages for Community-Onset Sepsis
2
Vigilance, Training, and Funding are Key for Outbreak and Pandemic Biopreparedness
3
Top Infectious Disease News Stories Week of December 20 - December 26
4